Impact of Climate Change Anxiety on Sinusitis Symptoms and Quality of Life Among Adults With Chro… (NCT07119879) | Clinical Trial Compass
CompletedNot Applicable
Impact of Climate Change Anxiety on Sinusitis Symptoms and Quality of Life Among Adults With Chronic Rhinosinusitis: A Cross-Sectional Study
Egypt134 participantsStarted 2025-01-01
Plain-language summary
This cross-sectional observational study investigates the relationship between climate change anxiety and chronic rhinosinusitis (CRS) symptom severity and quality of life (QoL) in adults. As climate change continues to influence public health, individuals with chronic respiratory diseases may experience worsened symptoms due to heightened psychological stress and perceived environmental instability. The study utilizes standardized instruments including the SNOT-22 (Sino-Nasal Outcome Test), a QoL scale, and a climate change anxiety questionnaire to evaluate associations among these variables.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
Participants must meet all of the following:
Adults aged 18 years or older Self-reported or clinically diagnosed with Chronic Rhinosinusitis (CRS) with symptoms lasting ≥12 weeks Able to read and understand Arabic Able to complete the online questionnaire independently Provided informed consent prior to participation Exclusion Criteria
Participants will be excluded if they meet any of the following:
Diagnosis of severe psychiatric or psychological disorders (e.g., schizophrenia, bipolar disorder) History of major chronic illnesses that may confound outcomes (e.g., cardiovascular disease, cancer, chronic neurological disease) Recent nasal or sinus surgery within the past 3 months Incomplete survey responses that prevent data analysis Participants under 18 years of age
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Correlation between Climate Change Anxiety and CRS Symptom Severity
Timeframe: Day 1 (Single assessment at time of survey completion)